Teleflex's Unit Gets 510(k) Marketing Clearance For Arrow GPSCath Catheters

(RTTNews) - Teleflex Inc. (TFX), a provider of medical devices for critical care and surgery, Tuesday said its unit Hotspur Technologies, Inc. received the U S Food and Drug Administration or FDA's 510(k) clearance to market its Arrow GPSCath Balloon Dilatation Catheters, designed for use with .014 inch guide wires and in 150 cm length. This product enables doctors to perform peripheral below the knee angioplasty in an easier manner, potentially reducing procedure time, radiation dosage, and expense for both patients and medical professionals. The Arrow GPSCath Balloon Dilatation Catheter is the first dual functional balloon dilatation catheter that combines angioplasty with the proprietary VisioValveInjection System, said the company.